CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Soliton Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Soliton Inc
5304 Ashbrook Dr
Phone: (832) 661-3453p:832 661-3453 HOUSTON, TX  77081-4102  United States Fax: (302) 655-5049f:302 655-5049

This company was Merged or Acquired on 12/16/2021.
This company ceased filing statements with the SEC on 12/28/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Soliton Inc is a medical technology company. The Company is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). It develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It’s designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202112/31/2020YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board, Co-Founder Walter V.Klemp 61 6/1/2018 6/1/2018
President, Chief Executive Officer, Director BradleyHauser 43 11/2/2020 6/15/2018
Vice Chairman of the Board, Chief Scientific Officer ChristopherCapelli 61 10/30/2020 9/1/2015
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 13 (As of 12/31/2020)
Outstanding Shares: 21,596,544 (As of 9/30/2021)
Shareholders: 86
Stock Exchange: NASD
Federal Tax Id: 364729076
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 31, 2024